Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22421124.
- Also identified by DOI 10.1016/j.jaad.2011.11.961 and PMC identifier 7357210.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dermatologists are ideally suited to manage the various cutaneous sequelae of graft-versus-host disease (GVHD) outlined in part I of this review. However, the complexity of the patient with GVHD, including comorbidities, potential drug interactions related to polypharmacy, and the lack of evidence-based treatment guidelines, are significant challenges to optimizing patient care. In this section, we will provide an outline for the role of the dermatologist in a multispecialty approach to caring for patients with GVHD.
Medical subject headings
- Graft vs Host Disease